| Stella Maris Inc Hospice Care 2300 Dulaney Valley Rd, Timonium, MD, 21093 | |
| (410) 252-4500 |
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| Name | Stella Maris Inc Hospice Care |
|---|---|
| Location | 2300 Dulaney Valley Rd, Timonium, Maryland |
| Hospice ID | 211500 |
| Category | Freestanding Hospice |
| Ownership Type | Other |
| Profit Type | OTHER |
| SSA county code | 020 |
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| NPI Number | 1174708242 |
| Organization Name | Stella Maris Inc. |
| Address | 2300 Dulaney Valley Rd Timonium, Maryland, 21093 |
| Phone Number | (410)252-4500 |
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| NPI Number | 1366559064 |
| Organization Name | Stella Maris Inc. |
| Address | 2300 Dulaney Valley Rd Timonium, Maryland, 21093 |
| Phone Number | (410)252-4500 |
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 72.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.8 | 93.3 |
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| Home Health Aides | 17.2 |
| Counselors | 4 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 4.6 |
| Registered Nurses | 37.6 |
| Total Employees | 65.4 |
|---|
News Archive
Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.
West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.
Patients, carers, scientists, clinicians and charities from across the UK are heading to Westminster today for the launch of a ground-breaking new collaborative partnership between the charity Brain Tumour Research and Plymouth University Peninsula Schools of Medicine and Dentistry. The announcement will open a new chapter in long-term sustainable and continuous research into the biggest cancer killer of children and adults under 40.
In a controlled study of smokers, nonsmokers, and e-cigarette users, University of North Carolina School of Medicine researchers found that e-cigarette users exhibited significantly altered immune responses to a model of influenza virus infection, suggesting increased susceptibility to disease.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 6 days ago
| Stella Maris Inc Hospice Care Location: 2300 Dulaney Valley Rd, Timonium, Maryland, 21093 Phone: (410) 252-4500 |